Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03763422
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:19.144344+00:00
Published At
2022-02-01T00:00:00+00:00
Record Updated At
2022-02-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Low-grade Glioma", "Temozolomide", "Phase III", "Wait or Treat"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-02-01"
protocolSection.identificationModule.nctId
"NCT03763422"
protocolSection.identificationModule.officialTitle
"IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Low-grade Glioma (protocolSection.conditionsModule.conditions)
  • Temozolomide (protocolSection.conditionsModule.conditions)
  • Phase III (protocolSection.conditionsModule.conditions)
  • Wait or Treat (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.